BIMINI Biotech
PrivateLast Round
Seed
Jan 8, 2025
Total Funding Raised
$3.89M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BIMINI Biotech is a preclinical stage biotechnology company developing novel first-in-class small molecule therapeutics for oncology with a focus on lymphomas and leukemia.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BIMINI Biotech Comparables
Compare BIMINI Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Flindr Therapeutics | 76% | |
| Dimericon Therapeutics | 73% | |
| Solu Therapeutics | 69% |
BIMINI Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 8, 2025 | ||||
| Seed | Jun 29, 2023 | ||||
| Seed | Oct 15, 2021 | ||||
| Pre Seed | Nov 26, 2020 |
Key People
Founding team and executive leadership
BIMINI Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Libertatis Ergo Holding | Seed |
| Torrey Pines Investment LLC | Seed |
| InnovationQuarter | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 53% MoM.
- Jan 6, 2026
Dr. Helmuth van Es joins as Independent Supervisory Board Member.
BIMINI Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BIMINI Biotech's valuation, stock price, and market status.
Is BIMINI Biotech a public or private company?
BIMINI Biotech is a private company.
What is the current stock price of BIMINI Biotech?
BIMINI Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is BIMINI Biotech worth (valuation)?
Valuation information for BIMINI Biotech is not publicly available.
Can I buy BIMINI Biotech stock?
BIMINI Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BIMINI Biotech's last funding round?
BIMINI Biotech's most recent funding round was Seed on January 8, 2025.
Who are the main investors in BIMINI Biotech?
Key investors in BIMINI Biotech include Libertatis Ergo Holding, Torrey Pines Investment LLC, InnovationQuarter.
Will BIMINI Biotech IPO soon?
No public IPO plans have been announced for BIMINI Biotech.
How can I track BIMINI Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BIMINI Biotech's secondary market activity and sign up for updates.